Rein Therapeutics (RNTX) Exchange Rate Effect (2023 - 2025)
Rein Therapeutics (RNTX) posted quarterly Exchange Rate Effect of -$18000.0 for Q4 2025, down 1700.0% year-over-year from $1125.0 in Q4 2024, and up 30.77% quarter-over-quarter from -$26000.0 in Q3 2025.
Rein Therapeutics (RNTX) Exchange Rate Effect (2023 - 2025) Analysis & Trends
Rein Therapeutics (RNTX) has reported Exchange Rate Effect for 3 consecutive years, with -$18000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 1700.0% year-over-year to -$18000.0; the TTM figure through Dec 2025 stood at -$45000.0 (up 29.69% YoY), while the FY2025 annual figure was -$44000.0, changed N/A from the prior year.
- Exchange Rate Effect advanced to -$18000.0 in Q4 2025 per RNTX's latest filing, from -$26000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at -$1000.0 in Q4 2024 and bottomed at -$63000.0 in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$27000.0 across 3 years, with a median of -$22000.0 in 2025.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect surged 98.41% — and 2025, when it plunged 1700.0%.
- Rein Therapeutics' Exchange Rate Effect stood at -$63000.0 in 2023, then soared by 98.41% to -$1000.0 in 2024, then slumped by 1700.0% to -$18000.0 in 2025.
- Business Quant data shows RNTX's Exchange Rate Effect at -$18000.0 in Q4 2025, -$26000.0 in Q3 2025, and -$1000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | - |
| 10 | Rein Therapeutics | 55.62 Mn | 55.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -63,000.00 |
| Dec 31, 2023 | -63,000.00 |